Wacker M, Linton D, Hitchen PG, Nita-Lazar M, Haslam SM, North SJ, Panico M, Morris HR, Dell A, Wren BW, Aebi M. N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli. Science. 2002 Nov 29;298(5599):1790-3. Available at link

Feldman MF, Wacker M, Hernandez M, Hitchen PG, Marolda CL, Kowarik M, Morris HR, Dell A, Valvano MA, Aebi M. Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli. Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):3016-21. Epub 2005 Feb 9. Available at link

Ilg K, Endt K, Misselwitz B, Stecher B, Aebi M, Hardt WD. O-antigen-negative Salmonella enterica serovar Typhimurium is attenuated in intestinal colonization but elicits colitis in streptomycin-treated mice. Infect Immun. 2009 Jun;77(6):2568-75. Epub 2009 Apr 13. Available at link

Silva J, Leite D, Fernandes M, Mena C, Gibbs P, Teixeira P. Campylobacter spp. as a food borne pathogen: a review. Frontiers in Food Microbiology. 2011 Sep . Available at link

Rosenqhist H., Nielsen N., Sommer H., Christensen B. Quantitative risk assessment of human campylobacteriosis associated with theomorphic Campylobacter species in chicken. Int J Food Microbiol 2003 83(1):87-103. Available at  link

EFSA: The European Union Summary Report On Trends and Sources Of Zoonoses, Zoonotic Agents And Food-Borne Outbreaks in 2016. Available at link

EFSA Scientific Opinion On Campylobacter In Broiler Meat Production. Available at link.


Buettner FF, Konze SA, Maas A, Gerlach GF. Proteomic and immunoproteomic characterization of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae. Proteome Sci. 2011 Apr 20;9(1):23. Available at link

Maas A, Jacobsen ID, Meens J, Gerlach GF. Use of an Actinobacillus pleuropneumoniae multiple mutant as a vaccine that allows differentiation of vaccinated and infected animals. Infect Immun. 2006 Jul;74(7):4124-32. Available at link

Oldfield NJ, Donovan EA, Worrall KE, Wooldridge KG, Langford PR, Rycroft AN, Ala'Aldeen DA. Identification and characterization of novel antigenic vaccine candidates of Actinobacillus pleuropneumoniae. Vaccine. 2008 Apr 7;26(16):1942-54. Epub 2008 Feb 27. Available at link

O'Neill C, Jones SC, Bossé JT, Watson CM, Williamson SM, Rycroft AN, Kroll JS, Hartley HM, Langford PR. Prevalence of Actinobacillus pleuropneumoniae serovars in England and Wales. Vet Rec. 2010 Oct 23;167(17):661-2. Available at link

Ramjeet M, Deslandes V, Gouré J, Jacques M. Actinobacillus pleuropneumoniae vaccines: from bacterins to new insights into vaccination strategies. Anim Health Res Rev. 2008 Jun;9(1):25-45. Epub 2008 Mar 17. Available at link

Sjölund M, Wallgren P. Field experience with two different vaccination strategies aiming to control infections with Actinobacillus pleuropneumoniae in a fattening pig herd. Acta Vet Scand. 2010 Mar 25;52:23. Available at link

Naegeli A, Neupert C, Fan YY, Lin CW, Poljak K, Papini AM, Schwarz F, Aebi M. Molecular analysis of an alternative N-glycosylation machinery by functional transfer from Actinobacillus pleuropneumoniae to Escherichia coli. J Biol Chem. 2014 Jan 24;289(4):2170-9. Available at link


Anon 2015. The European Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2013. Available at link

Anon 2011. Discontools Disease Database. Available at link

Latest News

  • 21 January 2019

    Malcisbo has been selected as emerging company to present at the Animal Health Investment Forum in London (Feb 2019)

  • 26 November 2018

    VetBioNet grant

    Malcisbo wins a grant to perform an APP challenge trial in a BLS3 facility.

  • 25 January 2017

    Malcisbo has been selected as emerging company to present at the Animal Health Investment Forum in London (Feb 2017)